Complete Filing Data
Inspire Medical Systems, Inc. reported Net Income Loss of $145.42 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Inspire Medical Systems, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $145.4M | $53.5M | -$21.2M | -$44.9M | -$42.0M | -$57.2M | -$33.2M | -$21.8M | -$17.5M | -$18.5M |
| Cost of Revenue * | $133.2M | $123.0M | $96.6M | $66.1M | $33.3M | $17.6M | $13.6M | $10.1M | $6.0M | $3.9M |
| Revenue * | $912.0M | $802.8M | $624.8M | $407.9M | $233.4M | $115.4M | $82.1M | $50.6M | $28.6M | $16.4M |
| Gross Profit | $778.8M | $679.8M | $528.2M | $341.7M | $200.1M | $97.8M | $68.4M | $40.5M | $22.5M | $12.5M |
| Research And Development Expense | $103.2M | $114.1M | $116.5M | $68.6M | $37.4M | $26.1M | $12.8M | $7.4M | $6.2M | $7.1M |
| Other Nonoperating Income Expense | -$2.7M | -$855.0K | -$195.0K | -$49.0K | -$117.0K | $145.0K | $12.0K | -$16.0K | $42.0K | -$29.0K |
| Operating Income Loss | $51.0M | $36.1M | -$40.3M | -$47.6M | -$39.9M | -$56.2M | -$34.9M | -$20.4M | -$16.0M | -$17.3M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $65.7M | $58.5M | -$19.9M | -$44.3M | -$42.0M | -$57.1M | -$33.2M | -$21.8M | -$17.5M | -$18.5M |
| Comprehensive Income Net Of Tax | $145.4M | $53.2M | -$20.3M | -$44.9M | -$42.1M | -$57.3M | -$33.1M | -$21.9M | -$17.5M | -$18.5M |
| Income Tax Expense Benefit | -$79.7M | $4.9M | $1.2M | $613.0K | $72.0K | $115.0K | $40.0K | $0.00 | $0.00 | $0.00 |
| Nonoperating Income Expense | $14.7M | $22.4M | $20.4M | $3.3M | -$2.1M | -$880.0K | $1.7M | -$1.5M | -$1.5M | -$1.3M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$72.0K | -$264.0K | $886.0K | -$31.0K | -$84.0K | -$73.0K | $154.0K | -$52.0K | ||
| Operating Expenses | $568.5M | $389.3M | $240.0M | $154.0M | $103.3M | $60.9M | $38.6M | $29.8M | ||
| Interest Expense | $0.00 | $1.7M | $2.1M | $2.1M | $2.1M | $3.3M | $1.8M | $1.3M | ||
| General And Administrative Expense | ||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$296.0K | -$65.0K | $140.0K | $89.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $9.9M | -$3.6M | $3.0M | $18.5M | $9.8M | -$10.0M | -$8.5M | -$12.0M | -$15.4M | -$16.8M | -$14.5M | -$16.7M | -$10.3M | -$13.1M | -$16.2M | -$7.5M | -$10.4M | -$23.1M | -$16.2M | -$9.1M | -$8.2M | -$7.7M | -$8.3M | -$4.8M | -$4.7M | -$5.9M | -$6.5M | -$4.3M | -$4.0M | -$4.8M | -$4.5M |
| Cost of Revenue * | $31.8M | $34.7M | $30.7M | $32.4M | $29.8M | $24.8M | $24.4M | $24.3M | $19.9M | $19.8M | $14.2M | $10.0M | $8.6M | $7.5M | $6.0M | $5.2M | $2.0M | $3.3M | $3.5M | $3.1M | $2.9M | $2.5M | $2.1M | $2.3M | $1.6M | $1.4M | $1.2M | ||||
| Revenue * | $224.5M | $217.1M | $201.3M | $203.2M | $195.9M | $164.0M | $153.3M | $151.1M | $127.9M | $109.2M | $91.4M | $69.4M | $61.7M | $53.0M | $40.4M | $46.0M | $35.8M | $12.2M | $21.3M | $26.9M | $20.9M | $18.0M | $16.3M | $16.6M | $13.1M | $10.9M | $10.0M | $10.0M | $7.3M | $6.0M | $5.3M |
| Gross Profit | $192.7M | $182.4M | $170.6M | $170.8M | $166.0M | $139.3M | $128.9M | $126.8M | $108.0M | $89.4M | $77.2M | $59.4M | $53.1M | $45.4M | $34.4M | $38.8M | $30.6M | $10.2M | $18.1M | $22.7M | $17.4M | $14.9M | $13.4M | $13.4M | $10.6M | $8.8M | $7.7M | $8.1M | $5.7M | $4.7M | $4.1M |
| Research And Development Expense | $24.2M | $26.2M | $27.8M | $26.1M | $28.9M | $28.9M | $29.1M | $30.8M | $25.5M | $21.0M | $14.5M | $11.9M | $9.6M | $9.3M | $8.2M | $7.3M | $6.1M | $5.4M | $3.6M | $2.8M | $2.6M | $1.8M | $1.7M | $1.7M | $1.2M | $1.7M | $1.6M | ||||
| Other Nonoperating Income Expense | -$66.0K | -$3.5M | $578.0K | $118.0K | -$135.0K | -$60.0K | -$224.0K | -$61.0K | $17.0K | -$101.0K | -$144.0K | -$45.0K | -$33.0K | -$19.0K | -$38.0K | $2.0K | $3.0K | $78.0K | $30.0K | $13.0K | -$38.0K | -$5.0K | -$17.0K | $19.0K | -$1.0K | $4.0K | -$1.0K | ||||
| Operating Income Loss | $9.6M | -$3.3M | -$1.5M | $14.3M | $5.1M | -$15.2M | -$13.5M | -$16.6M | -$19.5M | -$17.2M | -$14.0M | -$16.1M | -$9.8M | -$12.5M | -$15.7M | -$9.9M | -$22.8M | -$16.4M | -$8.7M | -$8.2M | -$8.8M | -$4.6M | -$5.6M | -$5.2M | -$3.6M | -$4.4M | -$4.1M | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $13.6M | -$2.3M | $4.2M | $20.3M | $10.8M | -$9.4M | -$8.2M | -$11.7M | -$15.2M | -$16.6M | -$14.3M | -$16.6M | -$10.3M | -$13.1M | -$16.2M | -$10.3M | -$23.1M | -$16.2M | -$8.2M | -$7.7M | -$8.3M | -$4.7M | -$5.9M | -$6.5M | -$4.0M | -$4.8M | -$4.5M | ||||
| Comprehensive Income Net Of Tax | $10.2M | -$3.4M | $2.7M | $20.3M | $9.6M | -$10.7M | -$8.6M | -$11.9M | -$15.3M | -$17.0M | -$14.5M | -$16.8M | -$10.3M | -$13.1M | -$16.2M | -$10.5M | -$23.2M | -$16.1M | -$8.2M | -$7.6M | -$8.2M | -$4.7M | -$5.9M | -$6.5M | -$4.0M | -$4.8M | -$4.5M | ||||
| Income Tax Expense Benefit | $3.6M | $1.3M | $1.2M | $1.8M | $1.1M | $650.0K | $340.0K | $214.0K | $216.0K | $246.0K | $142.0K | $100.0K | $3.0K | $26.0K | $23.0K | $87.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Nonoperating Income Expense | $3.9M | $984.0K | $5.6M | $6.0M | $5.7M | $5.9M | $5.3M | $4.9M | $4.3M | $593.0K | -$341.0K | -$538.0K | -$548.0K | -$518.0K | -$504.0K | -$406.0K | -$275.0K | $195.0K | $404.0K | $526.0K | $511.0K | -$44.0K | -$219.0K | -$1.3M | -$374.0K | -$372.0K | |||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $243.0K | $169.0K | -$309.0K | $1.8M | -$239.0K | -$676.0K | -$59.0K | $71.0K | $118.0K | -$162.0K | -$3.0K | -$143.0K | $3.0K | -$21.0K | -$20.0K | -$81.0K | -$141.0K | $193.0K | $39.0K | $35.0K | $68.0K | -$26.0K | |||||||||
| Operating Expenses | $156.5M | $160.9M | $154.5M | $142.4M | $143.4M | $127.5M | $106.6M | $91.2M | $75.4M | $62.9M | $58.0M | $50.1M | $40.5M | $33.0M | $34.5M | $26.1M | $23.1M | $22.2M | $15.2M | $14.5M | $12.9M | $9.4M | $9.1M | $8.2M | |||||||
| Interest Expense | $0.00 | $0.00 | $0.00 | $656.0K | $494.0K | $527.0K | $537.0K | $530.0K | $523.0K | $533.0K | $526.0K | $525.0K | $529.0K | $523.0K | $537.0K | $680.0K | $550.0K | $1.4M | $428.0K | ||||||||||||
| General And Administrative Expense | $130.4M | $132.1M | $125.6M | $113.2M | $112.6M | $102.0M | $85.6M | $76.7M | $63.6M | $53.2M | $48.7M | $41.9M | $33.2M | $27.0M | $29.1M | $22.4M | $20.3M | $19.6M | $13.5M | $12.7M | $11.2M | $864.0K | $801.0K | $887.0K | |||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$59.0K | $191.0K | -$300.0K | $259.0K | -$39.0K | -$134.0K | -$181.0K | $72.0K | $105.0K | -$148.0K | $42.0K | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $781.2M | $689.7M | $572.5M | $496.0M | $229.0M | $229.7M | $139.8M | $164.0M | $1.3M | -$6.6M | -$1.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $104.8M | $150.2M | $185.5M | $441.6M | $214.5M | $190.5M | $22.9M | $97.3M | $9.0M | $6.7M | |
| Unrealized Gain Loss On Investments | $224.0K | -$199.0K | $746.0K | -$120.0K | -$84.0K | -$73.0K | $154.0K | -$52.0K | |||
| Allowance For Doubtful Accounts Receivable Current | $1.1M | $880.0K | $1.6M | $36.0K | $99.0K | $42.0K | $48.0K | $47.0K | $47.0K | ||
| Cash And Cash Equivalents At Carrying Value | $104.8M | $150.2M | $185.5M | $441.6M | $214.5M | $190.5M | $22.9M | $97.3M | $6.7M | $12.1M | |
| Retained Earnings Accumulated Deficit | -$146.5M | -$291.9M | -$345.4M | -$324.3M | -$279.4M | -$237.3M | -$180.2M | -$146.9M | -$125.1M | ||
| Property Plant And Equipment Net | $97.9M | $71.9M | $40.0M | $17.2M | $8.5M | $5.3M | $3.0M | $802.0K | $994.0K | ||
| Liabilities Current | $96.1M | $88.5M | $78.1M | $61.2M | $41.3M | $20.7M | $16.9M | $11.2M | $7.1M | ||
| Liabilities And Stockholders Equity | $907.3M | $808.4M | $676.8M | $564.9M | $295.1M | $281.2M | $181.3M | $200.1M | $25.1M | ||
| Inventory Net | $145.3M | $80.1M | $33.9M | $11.9M | $17.2M | $8.5M | $5.8M | $2.7M | $3.7M | ||
| Common Stock Value | $29.0K | $30.0K | $30.0K | $29.0K | $27.0K | $27.0K | $24.0K | $23.0K | $1.0K | ||
| Assets Current | $583.7M | $630.8M | $593.7M | $530.0M | $268.5M | $269.9M | $170.6M | $199.3M | $24.1M | ||
| Assets | $907.3M | $808.4M | $676.8M | $564.9M | $295.1M | $281.2M | $181.3M | $200.1M | $25.1M | ||
| Accrued Liabilities Current | $59.5M | $49.8M | $39.3M | $34.3M | $20.5M | $13.5M | $12.4M | $7.7M | $4.1M | ||
| Accounts Receivable Net Current | $119.7M | $93.1M | $89.9M | $61.2M | $34.2M | $25.1M | $13.1M | $6.7M | $3.9M | ||
| Accounts Payable Trade Current | $36.6M | $38.7M | $38.8M | $26.8M | $11.7M | $7.2M | $4.5M | $3.4M | $3.0M | ||
| Short Term Investments | $203.5M | $295.4M | $274.8M | $9.8M | $0.00 | $43.8M | $126.6M | $90.9M | $7.2M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $464.0K | $536.0K | $800.0K | -$86.0K | -$55.0K | $29.0K | $102.0K | -$52.0K | $0.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$45.3M | -$35.4M | -$256.1M | $227.1M | $23.9M | $167.7M | -$74.4M | $88.3M | $2.3M | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $119.1M | ||
| Liabilities | $126.2M | $118.7M | $104.3M | $68.9M | $66.0M | $51.4M | $41.4M | $36.1M | $23.8M | ||
| Operating Lease Right Of Use Asset | $23.5M | $23.3M | $22.7M | $6.9M | $7.9M | $5.8M | $915.0K | ||||
| Other Liabilities Noncurrent | $104.0K | $148.0K | $1.3M | $146.0K | $134.0K | $85.0K | $40.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $666.5M | $677.8M | $635.7M | $696.6M | $638.1M | $589.0M | $572.5M | $544.2M | $529.4M | $504.6M | $496.0M | $470.2M | $227.0M | $225.1M | $229.0M | $220.3M | $219.9M | $223.1M | $229.7M | $228.8M | $233.6M | $127.4M | $139.8M | $146.1M | $152.5M | $157.4M | $164.0M | $98.3M | $102.6M | -$4.9M | $1.3M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $112.8M | $106.9M | $53.9M | $147.5M | $188.0M | $175.4M | $329.9M | $467.1M | $442.1M | $417.8M | $186.6M | $203.3M | $210.2M | $176.5M | $182.3M | $178.7M | $211.2M | $76.1M | $48.0M | $51.3M | $101.9M | $26.3M | $121.9M | |||||||||||
| Unrealized Gain Loss On Investments | $302.0K | -$22.0K | -$9.0K | $1.6M | -$200.0K | -$542.0K | $122.0K | -$1.0K | $13.0K | -$14.0K | -$45.0K | -$143.0K | $3.0K | -$21.0K | -$20.0K | -$81.0K | -$141.0K | $193.0K | $39.0K | $35.0K | $68.0K | -$26.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Allowance For Doubtful Accounts Receivable Current | $1.1M | $1.2M | $1.2M | $515.0K | $515.0K | $256.0K | $1.4M | $917.0K | $36.0K | $34.0K | $32.0K | $99.0K | $95.0K | $32.0K | $35.0K | $42.0K | $34.0K | $47.0K | $47.0K | $47.0K | ||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $112.8M | $106.9M | $53.9M | $147.5M | $188.0M | $175.4M | $329.9M | $467.1M | $442.1M | $417.8M | $186.6M | $203.3M | $210.2M | $176.5M | $182.3M | $178.7M | $211.2M | $76.1M | $48.0M | $51.3M | $101.9M | $26.3M | $121.9M | $11.1M | $9.0M | $14.5M | $22.5M | $26.6M | ||||||
| Retained Earnings Accumulated Deficit | -$282.6M | -$292.5M | -$288.9M | -$327.1M | -$345.6M | -$355.4M | -$360.2M | -$351.6M | -$339.7M | -$327.4M | -$310.6M | -$296.1M | -$277.0M | -$266.7M | -$253.6M | -$229.9M | -$219.5M | -$196.4M | -$171.1M | -$162.8M | -$155.2M | -$142.1M | -$137.4M | -$131.6M | ||||||||||
| Property Plant And Equipment Net | $91.5M | $85.3M | $77.2M | $67.4M | $61.7M | $52.3M | $32.2M | $25.2M | $20.9M | $14.1M | $11.0M | $9.3M | $7.9M | $7.1M | $6.8M | $4.3M | $3.3M | $3.1M | $2.8M | $1.8M | $974.0K | $765.0K | $865.0K | $911.0K | ||||||||||
| Liabilities Current | $110.8M | $93.4M | $63.5M | $74.3M | $65.7M | $72.2M | $70.0M | $66.7M | $59.9M | $49.3M | $46.9M | $43.2M | $33.6M | $24.4M | $19.4M | $18.2M | $13.0M | $13.7M | $12.7M | $8.7M | $7.8M | $7.6M | $9.3M | $7.9M | ||||||||||
| Liabilities And Stockholders Equity | $807.7M | $802.2M | $730.8M | $796.2M | $728.4M | $685.8M | $639.5M | $618.2M | $571.8M | $527.5M | $292.0M | $289.7M | $278.9M | $272.2M | $273.4M | $271.8M | $271.3M | $165.7M | $183.2M | $185.6M | $189.6M | $130.7M | $133.9M | $27.9M | ||||||||||
| Inventory Net | $141.8M | $121.6M | $99.7M | $67.4M | $59.0M | $49.0M | $26.1M | $20.8M | $15.7M | $15.1M | $21.9M | $22.2M | $15.6M | $13.3M | $11.4M | $9.0M | $10.0M | $7.2M | $4.7M | $3.6M | $3.1M | $3.1M | $3.5M | $3.4M | ||||||||||
| Common Stock Value | $29.0K | $29.0K | $29.0K | $30.0K | $30.0K | $30.0K | $29.0K | $29.0K | $29.0K | $29.0K | $28.0K | $28.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $24.0K | $24.0K | $24.0K | $24.0K | $21.0K | $21.0K | $1.0K | ||||||||||
| Assets Current | $586.5M | $573.2M | $571.7M | $582.5M | $607.2M | $572.2M | $569.6M | $560.1M | $533.6M | $495.5M | $263.1M | $262.5M | $255.5M | $249.5M | $260.8M | $266.9M | $267.1M | $155.4M | $170.5M | $177.2M | $188.5M | $130.0M | $133.0M | $26.9M | ||||||||||
| Assets | $807.7M | $802.2M | $730.8M | $796.2M | $728.4M | $685.8M | $639.5M | $618.2M | $571.8M | $527.5M | $292.0M | $289.7M | $278.9M | $272.2M | $273.4M | $271.8M | $271.3M | $165.7M | $183.2M | $185.6M | $189.6M | $130.7M | $133.9M | $27.9M | ||||||||||
| Accrued Liabilities Current | $51.6M | $40.2M | $34.3M | $39.3M | $32.0M | $28.4M | $30.0M | $26.7M | $23.4M | $29.0M | $18.6M | $13.9M | $17.5M | $12.6M | $10.4M | $11.5M | $7.9M | $7.9M | $7.9M | $6.0M | $4.6M | $5.0M | $4.2M | $3.1M | ||||||||||
| Accounts Receivable Net Current | $108.0M | $137.7M | $92.6M | $89.7M | $79.7M | $72.3M | $71.5M | $63.5M | $59.8M | $48.5M | $40.4M | $34.5M | $26.7M | $24.9M | $21.6M | $21.1M | $10.2M | $11.0M | $11.0M | $9.5M | $7.0M | $5.4M | $4.5M | $3.5M | ||||||||||
| Accounts Payable Trade Current | $59.2M | $53.2M | $29.1M | $34.9M | $33.6M | $43.8M | $40.0M | $40.0M | $36.5M | $20.3M | $16.0M | $17.0M | $10.0M | $8.7M | $9.1M | $6.7M | $5.1M | $5.8M | $4.8M | $2.7M | $3.2M | $2.4M | $2.2M | $3.9M | ||||||||||
| Short Term Investments | $209.7M | $194.0M | $315.3M | $263.5M | $251.6M | $265.9M | $134.3M | $0.00 | $9.9M | $9.7M | $9.8M | $0.00 | $31.3M | $43.8M | $55.9M | $31.3M | $59.6M | $103.6M | $107.4M | $75.1M | $94.1M | $2.1M | $6.8M | |||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $639.0K | $396.0K | $227.0K | $1.7M | -$115.0K | $124.0K | $44.0K | $103.0K | $32.0K | -$363.0K | -$201.0K | -$198.0K | -$9.0K | -$12.0K | $9.0K | $73.0K | $154.0K | $295.0K | $90.0K | $51.0K | $16.0K | -$26.0K | $0.00 | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$96.3M | -$10.1M | $540.0K | -$11.2M | -$8.2M | $53.3M | $4.7M | |||||||||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $119.1M | ||||||||||||||
| Liabilities | $141.3M | $124.4M | $95.1M | $99.6M | $90.3M | $96.8M | $95.3M | $88.9M | $67.2M | $57.3M | $65.0M | $64.7M | $58.6M | $52.3M | $50.3M | $43.0M | $37.7M | $38.3M | $37.2M | $33.1M | $32.2M | |||||||||||||
| Operating Lease Right Of Use Asset | $24.1M | $24.5M | $25.0M | $21.8M | $22.2M | $22.2M | $23.1M | $21.4M | $6.6M | $7.1M | $7.4M | $7.7M | $5.3M | $5.5M | $5.6M | $171.0K | $424.0K | $672.0K | $1.8M | |||||||||||||||
| Other Liabilities Noncurrent | $111.0K | $111.0K | $108.0K | $150.0K | $149.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $146.0K | $124.0K | $111.0K | $97.0K | $74.0K | $40.0K | $40.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $130.3M | $116.0M | $82.5M | $52.0M | $26.2M | $12.8M | $6.2M | $1.2M | $243.0K | $248.0K |
| Share Based Compensation | $130.3M | $116.0M | $82.5M | $52.0M | $26.2M | $12.8M | $6.2M | $1.2M | $243.0K | $248.0K |
| Payments To Acquire Property Plant And Equipment | $38.5M | $39.1M | $23.6M | $9.1M | $4.7M | $2.5M | $2.7M | $250.0K | $412.0K | $306.0K |
| Net Cash Provided By Used In Operating Activities | $117.0M | $130.2M | $24.7M | $11.6M | -$20.1M | -$53.0M | -$32.8M | -$18.7M | -$15.8M | -$17.9M |
| Net Cash Provided By Used In Investing Activities | $21.4M | -$113.1M | -$294.8M | -$19.6M | $29.1M | $86.6M | -$43.6M | -$83.4M | -$7.6M | -$306.0K |
| Net Cash Provided By Used In Financing Activities | -$183.4M | -$52.4M | $14.0M | $235.1M | $14.9M | $134.1M | $2.0M | $190.4M | $25.7M | $12.8M |
| Increase Decrease In Receivables | $26.2M | $2.6M | $30.2M | $27.0M | $9.2M | $11.8M | $6.5M | $2.8M | $1.8M | $760.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.7M | $2.3M | $4.8M | $2.8M | $696.0K | -$416.0K | $905.0K | $1.3M | $308.0K | -$88.0K |
| Increase Decrease In Inventories | $65.2M | $46.2M | $22.0M | -$5.3M | $8.8M | $2.6M | $3.2M | -$1.0M | $315.0K | -$612.0K |
| Increase Decrease In Accounts Payable | -$3.7M | $604.0K | $9.3M | $14.4M | $4.8M | $2.0M | $1.0M | $439.0K | $1.8M | -$480.0K |
| Depreciation Depletion And Amortization | $14.0M | $6.6M | $2.8M | $1.9M | $1.2M | $840.0K | $495.0K | $393.0K | $285.0K | $103.0K |
| Proceeds From Stock Options Exercised | $9.6M | $22.2M | $25.8M | $12.1M | $11.5M | $7.1M | $1.1M | $558.0K | $235.0K | $466.0K |
| Proceeds From Sale Maturity And Collections Of Investments | $310.4M | $344.6M | $10.2M | $0.00 | $43.8M | $141.8M | $137.3M | $32.3M | $1.8M | $0.00 |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$310.0K | -$118.0K | $164.0K | $75.0K | -$19.0K | $11.0K | ||||
| Increase Decrease In Accrued Liabilities | $3.6M | $1.3M | $783.0K | |||||||
| Proceeds From Issuance Of Common Stock From Employee Stock Purchase Plan | $5.0M | $5.6M | $5.3M | $3.7M | $3.5M | $2.4M | $1.4M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $29.5M | $41.7M | $31.1M | $28.2M | $32.3M | $26.3M | $19.8M | $21.6M | $18.2M | $14.6M | $12.7M | $9.7M | $6.8M | $6.3M | $6.0M | $3.3M | $2.9M | $2.7M | $1.5M | $1.4M | $1.4M | $372.0K | $269.0K | $55.0K | |
| Share Based Compensation | $29.5M | $41.7M | $31.1M | $28.2M | $32.3M | $26.3M | $18.2M | $9.7M | $6.0M | $2.7M | $1.4M | $55.0K | $54.0K | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $8.4M | $11.7M | $3.8M | $1.2M | $1.3M | $255.0K | $275.0K | $7.0K | $206.0K | ||||||||||||||||
| Net Cash Provided By Used In Operating Activities | -$6.7M | $8.9M | -$1.3M | -$12.7M | -$10.4M | -$14.8M | -$10.9M | -$6.4M | -$5.4M | ||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$1.6M | -$19.5M | -$3.8M | -$1.5M | -$1.3M | $67.2M | $16.0M | $425.0K | -$206.0K | ||||||||||||||||
| Net Cash Provided By Used In Financing Activities | -$87.8M | $768.0K | $5.6M | $3.0M | $3.6M | $787.0K | -$366.0K | $8.2M | $25.4M | ||||||||||||||||
| Increase Decrease In Receivables | -$263.0K | -$19.0M | -$1.5M | $382.0K | -$3.4M | -$2.1M | $385.0K | -$399.0K | $188.0K | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.8M | -$13.0K | $579.0K | -$216.0K | -$356.0K | -$775.0K | -$212.0K | $1.8M | $47.0K | ||||||||||||||||
| Increase Decrease In Inventories | $19.6M | $15.1M | $3.8M | $5.0M | $2.9M | $1.4M | $439.0K | -$276.0K | -$162.0K | ||||||||||||||||
| Increase Decrease In Accounts Payable | -$9.5M | $3.6M | $8.4M | $5.5M | $1.5M | $1.4M | -$222.0K | $918.0K | $127.0K | ||||||||||||||||
| Depreciation Depletion And Amortization | $3.0M | $839.0K | $593.0K | $359.0K | $234.0K | $187.0K | $103.0K | $90.0K | $43.0K | ||||||||||||||||
| Proceeds From Stock Options Exercised | $6.4M | $3.6M | $7.4M | $3.1M | $3.6M | $787.0K | $165.0K | $185.0K | $6.0K | ||||||||||||||||
| Proceeds From Sale Maturity And Collections Of Investments | $24.2M | $47.9M | $0.00 | $0.00 | $82.4M | $56.8M | $5.1M | ||||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$252.0K | -$214.0K | $6.0K | -$7.0K | $2.0K | $4.0K | $9.0K | ||||||||||||||||||
| Increase Decrease In Accrued Liabilities | -$12.4M | -$10.6M | -$6.9M | -$3.0M | -$4.5M | -$3.3M | -$825.0K | -$1.1M | |||||||||||||||||
| Proceeds From Issuance Of Common Stock From Employee Stock Purchase Plan |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $4.89 | $1.75 | -$0.72 | -$1.60 | -$1.54 | -$2.19 | -$1.40 | -$1.50 | -$14.88 | -$16.90 |
| Common Stock Shares Outstanding | 28.6M | 29.7M | 29.6M | 29.0M | 27.4M | 27.1M | 24.1M | 23.4M | 1.3M | |
| Common Stock Shares Issued | 28.6M | 29.7M | 29.6M | 29.0M | 27.4M | 27.1M | 24.1M | 23.4M | 1.3M | |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 110.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 29.4M | 29.8M | 29.3M | 28.1M | 27.3M | 26.1M | 23.8M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 29.8M | 30.5M | 29.3M | 28.1M | 27.3M | 26.1M | 23.8M | |||
| Earnings Per Share Basic | $4.95 | $1.80 | $-0.72 | $-1.60 | $-1.54 | $-2.19 | $-1.40 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 76.2M | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 76.2M | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 76.9M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.34 | -$0.12 | $0.10 | $0.60 | $0.32 | -$0.34 | -$0.29 | -$0.41 | -$0.53 | -$0.60 | -$0.53 | -$0.61 | -$0.38 | -$0.48 | -$0.60 | -$0.28 | -$0.39 | -$0.88 | -$0.67 | -$0.38 | -$0.34 | -$0.32 | -$0.35 | -$0.22 | -$0.22 | -$0.43 | -$5.05 | -$3.46 | -$3.42 | -$4.14 | -$3.90 |
| Common Stock Shares Outstanding | 29.1M | 29.6M | 29.5M | 30.0M | 29.8M | 29.7M | 29.4M | 29.3M | 29.2M | 28.8M | 27.6M | 27.6M | 27.4M | 27.3M | 27.2M | 26.9M | 26.8M | 24.4M | 24.0M | 23.9M | 23.5M | 21.4M | 21.4M | 1.4M | |||||||
| Common Stock Shares Issued | 29.1M | 29.6M | 29.5M | 30.0M | 29.8M | 29.7M | 29.4M | 29.3M | 29.2M | 28.8M | 27.6M | 27.6M | 27.4M | 27.3M | 27.2M | 26.9M | 26.8M | 24.4M | 24.0M | 23.9M | 23.5M | 21.4M | 21.4M | 1.4M | |||||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 110.0M | |||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Weighted Average Number Of Shares Outstanding Basic | 29.3M | 29.5M | 29.7M | 29.9M | 29.7M | 29.6M | 29.4M | 29.2M | 29.1M | 28.2M | 27.6M | 27.5M | 27.3M | 27.2M | 27.1M | 26.8M | 26.3M | ||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 29.6M | 29.5M | 30.3M | 30.6M | 30.4M | 29.6M | 29.4M | 29.2M | 29.1M | 28.2M | 27.6M | 27.5M | 27.3M | 27.2M | 27.1M | 26.8M | 26.3M | ||||||||||||||
| Earnings Per Share Basic | $0.34 | $-0.12 | $0.10 | $0.62 | $0.33 | $-0.34 | $-0.29 | $-0.41 | $-0.53 | $-0.60 | $-0.53 | $-0.61 | $-0.38 | $-0.48 | $-0.60 | $-0.39 | $-0.88 | ||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 76.2M | ||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 76.2M | ||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 76.9M | ||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $9.4M | $21.9M | $25.8M | $12.1M | $11.5M | $7.1M | $1.1M | $558.0K | $235.0K | $189.0K |
| Stock Issued During Period Value New Issues | $307.0K | $322.0K | $353.0K | $325.0K | $301.0K | $294.0K | $233.0K | $95.0K | $25.0M | $12.3M |
| Prepaid Expense Current | $10.4M | $12.1M | $9.6M | $5.5M | $2.7M | $2.0M | $2.2M | $1.7M | $426.0K | |
| Interest Paid Net | $137.0K | $22.0K | $0.00 | $2.3M | $1.9M | $1.9M | $2.0M | $2.0M | $1.3M | $1.2M |
| Additional Paid In Capital | $927.2M | $981.0M | $917.1M | $820.3M | $508.5M | $467.0M | $319.9M | $310.9M | $7.3M | |
| Investment Income Interest | $125.0K | $1.1M | $3.8M | $1.9M | $203.0K | $57.0K | ||||
| Sharebased Compensation Noncash Services | $353.0K | $325.0K | $301.0K | $294.0K | $233.0K | $95.0K | $0.00 | $0.00 | ||
| Investment Income Interest And Dividend | $17.5M | $23.2M | $20.6M | $5.1M | $125.0K | $1.1M | ||||
| Stock Issued During Period Shares Stock Options Exercised | 163.4K | 387.9K | 595.2K | 416.6K | 323.9K | 624.3K | 664.6K | 301.1K | 127.1K | 109.1K |
| Other Noncash Income Expense | -$2.0M | $549.0K | -$296.0K | -$113.0K | $143.0K | -$51.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $144.0K | $2.2M | $6.4M | $14.2M | $5.5M | $3.6M | $4.0M | $13.1M | $7.4M | $1.8M | $1.5M | $3.1M | $3.8M | $1.7M | $3.6M | $2.3M | $732.0K | $787.0K | $191.0K | $604.0K | $166.0K | $46.0K | $200.0K | $186.0K | |||
| Stock Issued During Period Value New Issues | $84.0K | $73.0K | $69.0K | $65.0K | $85.0K | $101.0K | $91.0K | $91.0K | $90.0K | $79.0K | $80.0K | $79.0K | $77.0K | $72.0K | $73.0K | $72.0K | $73.0K | $72.0K | $58.0K | $58.0K | $58.0K | $37.0K | $112.0M | ||||
| Prepaid Expense Current | $14.1M | $13.0M | $10.1M | $14.4M | $28.8M | $9.5M | $7.8M | $8.7M | $6.1M | $4.4M | $4.6M | $2.4M | $3.0M | $3.4M | $1.6M | $2.2M | $4.3M | $1.4M | $3.2M | $5.6M | $1.4M | $1.0M | $1.0M | $2.2M | |||
| Interest Paid Net | $0.00 | $466.0K | $466.0K | $471.0K | $771.0K | $347.0K | |||||||||||||||||||||
| Additional Paid In Capital | $948.4M | $969.9M | $924.4M | $1.02B | $983.8M | $944.3M | $904.3M | $880.9M | $844.3M | $798.0M | $537.7M | $521.3M | $497.3M | $486.6M | $476.7M | $458.6M | $452.9M | $323.5M | $317.0M | $315.2M | $312.6M | $240.5M | $240.0M | $7.5M | |||
| Investment Income Interest | $34.0K | $22.0K | $31.0K | $57.0K | $125.0K | $248.0K | $642.0K | $903.0K | $1.0M | $1.1M | $641.0K | $348.0K | $60.0K | $55.0K | $46.0K | $18.0K | |||||||||||
| Sharebased Compensation Noncash Services | $101.0K | $90.0K | $79.0K | $73.0K | $72.0K | $58.0K | $0.00 | ||||||||||||||||||||
| Investment Income Interest And Dividend | $4.0M | $4.5M | $5.1M | $5.9M | $5.9M | $5.9M | $5.5M | $4.9M | $4.3M | $1.4M | $297.0K | $34.0K | $22.0K | $31.0K | |||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 73.7K | 88.3K | 142.2K | 151.2K | 133.4K | 254.1K | 100.1K | ||||||||||||||||||||
| Other Noncash Income Expense | $1.0K | -$61.0K | $8.0K | $89.0K | $141.0K | $0.00 |
Most recent annual filing with the SEC: February 13, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.